Moreau JP - Search Results

1

Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.

Jaquet P, Saveanu A, Gunz G, Fina F, Zamora AJ, Grino M, Culler MD, Moreau JP, Enjalbert A, Ouafik LH. Jaquet P, et al. Among authors: moreau jp. J Clin Endocrinol Metab. 2000 Feb;85(2):781-92. doi: 10.1210/jcem.85.2.6338. J Clin Endocrinol Metab. 2000. PMID: 10690891

2

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.

Jaquet P, Gunz G, Saveanu A, Dufour H, Taylor J, Dong J, Kim S, Moreau JP, Enjalbert A, Culler MD. Jaquet P, et al. Among authors: moreau jp. Eur J Endocrinol. 2005 Jul;153(1):135-41. doi: 10.1530/eje.1.01950. Eur J Endocrinol. 2005. PMID: 15994755 Clinical Trial.

3

BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.

Jaquet P, Gunz G, Saveanu A, Barlier A, Dufour H, Taylor J, Dong J, Kim S, Moreau JP, Culler MD. Jaquet P, et al. Among authors: moreau jp. J Endocrinol Invest. 2005;28(11 Suppl International):21-7. J Endocrinol Invest. 2005. PMID: 16625841

4

Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas.

Jaquet P, Ouafik L, Saveanu A, Gunz G, Fina F, Dufour H, Culler MD, Moreau JP, Enjalbert A. Jaquet P, et al. Among authors: moreau jp. J Clin Endocrinol Metab. 1999 Sep;84(9):3268-76. doi: 10.1210/jcem.84.9.5962. J Clin Endocrinol Metab. 1999. PMID: 10487698

5

Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.

Saveanu A, Gunz G, Dufour H, Caron P, Fina F, Ouafik L, Culler MD, Moreau JP, Enjalbert A, Jaquet P. Saveanu A, et al. Among authors: moreau jp. J Clin Endocrinol Metab. 2001 Jan;86(1):140-5. doi: 10.1210/jcem.86.1.7099. J Clin Endocrinol Metab. 2001. PMID: 11231991

6

Somatostatin receptor subtypes: targeting functional and therapeutic specificity.

Culler MD, Taylor JE, Moreau JP. Culler MD, et al. Among authors: moreau jp. Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 3):2S5-12. Ann Endocrinol (Paris). 2002. PMID: 12037501 Review.

7

Improved analogs and novel delivery systems for somatostatin octapeptides.

Moreau JP, Kim S, Dong JZ, Ignatious F, Jackson S, Moreau SC, Morgan BA, Touraud F, Taylor JE, Tissier B, Pellet M, Murphy W, Davis T. Moreau JP, et al. Among authors: moreau sc. Metabolism. 1996 Aug;45(8 Suppl 1):24-6. doi: 10.1016/s0026-0495(96)90074-8. Metabolism. 1996. PMID: 8769374 Review.

8

Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.

Raynor K, Murphy WA, Coy DH, Taylor JE, Moreau JP, Yasuda K, Bell GI, Reisine T. Raynor K, et al. Among authors: moreau jp. Mol Pharmacol. 1993 Jun;43(6):838-44. Mol Pharmacol. 1993. PMID: 8100350

9

Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.

Murphy WA, Taylor JE, Moreau JP, Coy DH. Murphy WA, et al. Among authors: moreau jp. Pept Res. 1989 Jan-Feb;2(1):128-32. Pept Res. 1989. PMID: 2577697

10

[Somatostatin analogs in oncology].

Thomas F, Parmar H, Prevost G, Kuhn JM, Bejot JL, Moreau JP, Bogden A. Thomas F, et al. Among authors: moreau jp. Bull Cancer. 1991;78(8):693-707. Bull Cancer. 1991. PMID: 1681967 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page